Novoeight and Ustekinumab Subcutaneous
Determining the interaction of Novoeight and Ustekinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Novoeight-Ustekinumab Subcutaneous Injection
- Novoeight-Ustell
- Novoeight-UTA
- Novoeight-UTA Capsules
- Novoeight-UTAC tablets
- Novoeight-UTI Relief
- Ustekinumab Subcutaneous-Novoeight recombinant
- Ustekinumab Subcutaneous-Novolin 70/30
- Ustekinumab Subcutaneous-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Ustekinumab Subcutaneous-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Ustekinumab Subcutaneous-Novolin N
- Ustekinumab Subcutaneous-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))